Twelve members of Vanderbilt’s faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”
Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.
Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt investigators have discovered. The findings shed light on a long-standing question in infectious diseases and may inform new treatment strategies.
Vanderbilt University researchers are closer to understanding the link between obesity, chronic inflammation and type 2 diabetes.
Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.
A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.
Accessibility Tools